Novakand Pharma AB (publ) (LARK) — Cash Flow Quality Index
Novakand Pharma AB (publ) (LARK) has a Cash Flow Quality Index of 0.58x as of June 2026. Operating cash flow of Skr352.00K is below net income of Skr610.50K, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Novakand Pharma AB (publ) to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Novakand Pharma AB (publ) Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Novakand Pharma AB (publ) across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Novakand Pharma AB (publ) (LARK) net asset quality to measure how much of total assets are equity-financed.
Annual Cash Flow Quality Index for Novakand Pharma AB (publ) (2021–2021)
Year-by-year earnings quality comparison for Novakand Pharma AB (publ). For the full cash flow conversion analysis, see how efficiently does Novakand Pharma AB (publ) generate cash.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.05x | Skr22.11 Million | Skr20.96 Million | — |